Literature DB >> 32568390

Digit Ulcerations in a Young Woman.

Bibin Varghese1, Erin Chew1, Maximilian F Konig2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32568390      PMCID： PMC9365669          DOI： 10.1001/jama.2020.6084

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   157.335


× No keyword cloud information.
  10 in total

1.  The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Ricardo J Bello; Carisa M Cooney; Eitan Melamed; Keith Follmar; Gayane Yenokyan; Gwendolyn Leatherman; Ami A Shah; Fredrick M Wigley; Laura K Hummers; Scott D Lifchez
Journal:  Arthritis Rheumatol       Date:  2017-06-26       Impact factor: 10.995

Review 2.  Raynaud's Phenomenon.

Authors:  Fredrick M Wigley; Nicholas A Flavahan
Journal:  N Engl J Med       Date:  2016-08-11       Impact factor: 91.245

Review 3.  Evidence-based management of Raynaud's phenomenon.

Authors:  Ariane L Herrick
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-20       Impact factor: 5.346

4.  Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases.

Authors:  G Spencer-Green
Journal:  Arch Intern Med       Date:  1998-03-23

5.  Update of EULAR recommendations for the treatment of systemic sclerosis.

Authors:  Otylia Kowal-Bielecka; Jaap Fransen; Jerome Avouac; Mike Becker; Agnieszka Kulak; Yannick Allanore; Oliver Distler; Philip Clements; Maurizio Cutolo; Laszlo Czirjak; Nemanja Damjanov; Francesco Del Galdo; Christopher P Denton; Jörg H W Distler; Ivan Foeldvari; Kim Figelstone; Marc Frerix; Daniel E Furst; Serena Guiducci; Nicolas Hunzelmann; Dinesh Khanna; Marco Matucci-Cerinic; Ariane L Herrick; Frank van den Hoogen; Jacob M van Laar; Gabriela Riemekasten; Richard Silver; Vanessa Smith; Alberto Sulli; Ingo Tarner; Alan Tyndall; Joep Welling; Frederic Wigley; Gabriele Valentini; Ulrich A Walker; Francesco Zulian; Ulf Müller-Ladner
Journal:  Ann Rheum Dis       Date:  2016-11-09       Impact factor: 19.103

6.  A prospective study of the use of botulinum toxin injections in the treatment of Raynaud's syndrome associated with scleroderma.

Authors:  L Uppal; K Dhaliwal; P E Butler
Journal:  J Hand Surg Eur Vol       Date:  2013-12-24

Review 7.  Digital ulcers in systemic sclerosis.

Authors:  Michael Hughes; Ariane L Herrick
Journal:  Rheumatology (Oxford)       Date:  2016-04-19       Impact factor: 7.580

8.  Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.

Authors:  Martial Koenig; France Joyal; Marvin J Fritzler; André Roussin; Michal Abrahamowicz; Gilles Boire; Jean-Richard Goulet; Eric Rich; Tamara Grodzicky; Yves Raymond; Jean-Luc Senécal
Journal:  Arthritis Rheum       Date:  2008-12

9.  Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.

Authors:  V D Steen; T A Medsger
Journal:  Arthritis Rheum       Date:  1998-09

10.  Redefining the Scl-70 indirect immunofluorescence pattern: autoantibodies to DNA topoisomerase I yield a specific compound immunofluorescence pattern.

Authors:  Alessandra Dellavance; Cristiane Gallindo; Mariana Guanaes Soares; Neusa Pereira da Silva; Renato Arruda Mortara; Luís Eduardo Coelho Andrade
Journal:  Rheumatology (Oxford)       Date:  2009-04-24       Impact factor: 7.580
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.